Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats

Experimental Biology and Medicine

Volumn 239, Issue 2, 2014, Pages 225-231

  Barichello, Tatiana ^a   Generoso, Jaqueline S ^a   Michelon, Cleonice M ^a   Simões, Lutiana R ^a   Elias, Samuel G ^a   Vuolo, Franciele ^a,b   Comim, Clarissa M ^a   Dal Pizzol, Felipe ^a,b   Quevedo, João ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Laboratory of Experimental Physiopathology   (Brazil)

Author keywords

blood brain barrier; learning and memory; Meningitis; metalloproteinases 2 and 9; Streptococcus pneumoniae

Indexed keywords

BLOOD-BRAIN BARRIER; LEARNING AND MEMORY; MENINGITIS; METALLOPROTEINASES-2 AND 9; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BLOOD-BRAIN BARRIER; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; LEARNING; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MEMORY; MENINGITIS, PNEUMOCOCCAL; RATS; RATS, WISTAR; STREPTOCOCCUS PNEUMONIAE;

EID: 84893956393     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213508354     Document Type: Article

References (45)

1. Grimwood K,Nolan TM,Bond L,Anderson VA,Catroppa C,Keir EH.Risk factors for adverse outcomes of bacterial meningitis.J Paediatr Child Health. 1996;32:457-62.
2. Mook-Kanamori BB,Geldhoff M,van der Poll T,van de Beek D.Pathogenesis and pathophysiology of pneumococcal meningitis.Clin Microbiol Rev. 2011;24:557-91.
3. Barichello T,Generoso JS,Collodel A,Moreira AP,Almeida SM.Pathophysiology of acute meningitis caused by Streptococcus pneumoniae and adjunctive therapy approaches.Arq Neuropsiquiatr. 2012;70:366-72.
4. Leppert D,Lindberg RLP,Kappos L,Leib SL.Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.Brain Res Rev. 2001;36:249-57.
5. Kieseier BC,Paul R,Koedel U,Seifert T,Clements JM,Gearing AJ,Pfister HW,Hartung HP.Differential expression of matrix metalloproteinases in bacterial meningitis.Brain. 1999;122:1579-87.
6. Alexander CM,Werb Z.Proteinases and extracellular matrix remodeling.Curr Opin Cell Biol. 1989;1:974-82.
7. Planas AM,Sole S,Justicia C,Farre ER.Estimation of gelatinase content in rat brain: effect of focal ischemia.Biochem Biophys Res Commun. 2000;278:803-7.
8. Planas AM,Sole S,Justicia C.Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia.Neurobiol Dis. 2001;8:834-46.
9. Kim KS.Mechanisms of microbial traversal of the blood-brain barrier.Nat Rev Microbiol. 2008;6:625-34.
10. Kim KS.Microbial translocation of the blood-brain barrier.Int J Parasitol. 2006;36:607-14.
11. Barichello T,Generoso JS,Milioli G,Elias SG,Teixeira AL.Pathophysiology of bacterial infection of the central nervous system and its putative role in the pathogenesis of behavioral changes.Rev Bras Psiquiatr. 2013;35:81-7.
12. Sellner J, Täuber MG, Leib SL. Chapter 1 - pathogenesis and pathophysiology of bacterial CNS infections. In: Karen LR, Allan RT, eds. Handbook of Clinical Neurology. Elsevier, 2010:1-16.
13. Moreillon P,Majcherczyk PA.Proinflammatory activity of cell-wall constituents from gram-positive bacteria.Scand J Infect Dis. 2003;35:632-41.
14. Klein M,Koedel U,Pfister HW.Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy?.Prog Neurobiol. 2006;80:269-80.
15. Kastenbauer S,Koedel U,Becker BF,Pfister HW.Oxidative stress in bacterial meningitis in humans.Neurology. 2002;58:186-91.
16. Kastenbauer S,Koedel U,Pfister HW.Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis.J Infect Dis. 1999;180:1164-70.
17. Nathan BR,Scheld WM.New advances in the pathogenesis and pathophysiology of bacterial meningitis.Curr Infect Dis Rep. 2000;2:332-6.
18. Yong VW,Krekoski CA,Forsyth PA,Bell R,Edwards DR.Matrix metalloproteinases and diseases of the CNS.Trends Neurosci. 1998;21:75-80.
19. Shapiro S,Miller A,Lahat N,Sobel E,Lerner A.Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis.J Neurol Sci. 2003;206:43-8.
20. Barichello T,Pereira JS,Savi GD,Generoso JS,Cipriano AL,Silvestre C,Petronilho F,Dal-Pizzol F,Vilela MC,Teixeira AL.A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis.J Neuroimmunol. 2011;233:12-7.
21. Barichello T,Generoso JS,Silvestre C,Costa CS,Carrodore MM,Cipriano AL,Michelon CM,Petronilho F,Dal-Pizzol F,Vilela MC,Teixeira AL.Circulating concentrations, cerebral output of the CINC-1 and blood-brain barrier disruption in Wistar rats after pneumococcal meningitis induction.Eur J Clin Microbiol Infect Dis. 2012;31:2005-9.
22. Irazuzta JE,Pretzlaff RK,Zingarelli B,Xue V,Zemlan F.Modulation of nuclear factor-kappaB activation and decreased markers of neurological injury associated with hypothermic therapy in experimental bacterial meningitis.Crit Care Med. 2002;30:2553-9.
23. Dal-Pizzol F,Rojas HA,Dos Santos EM,Vuolo F,Constantino L,Feier G,Pasquali M,Comim CM,Petronilho F,Gelain DP,Quevedo J,Moreira JC,Ritter C.Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis.Mol Neurobiol. 2013;48:62-70.
24. Smith SL,Hall ED.Mild pre- and posttraumatic hypothermia attenuates blood-brain barrier damage following controlled cortical impact injury in the rat.J Neurotrauma. 1996;13:1-9.
25. Barichello T,Goncalves JC,Generoso JS,Milioli GL,Silvestre C,Costa CS,Coelho Jda R,Comim CM,Quevedo J.Attenuation of cognitive impairment by the nonbacteriolytic antibiotic daptomycin in Wistar rats submitted to pneumococcal meningitis.BMC Neurosci. 2013;14:42-42.
26. Vianna MR,Alonso M,Viola H,Quevedo J,de Paris F,Furman M,de Stein ML,Medina JH,Izquierdo I.Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat.Learn Mem. 2000;7:333-40.
27. de Lima MN,Laranja DC,Bromberg E,Roesler R,Schroder N.Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats.Behav Brain Res. 2005;156:139-43.
28. Medina JH,Schroder N,Izquierdo I.Two different properties of short- and long-term memory.Behav Brain Res. 1999;103:119-21.
29. Barichello T,dos Santos I,Savi GD,Simoes LR,Silvestre T,Comim CM,Sachs D,Teixeira MM,Teixeira AL,Quevedo J.TNF-alpha, IL-1beta, IL-6, and cinc-1 levels in rat brain after meningitis induced by Streptococcus pneumoniae.J Neuroimmunol. 2010;221:42-5.
30. Barichello T,Savi GD,Silva GZ,Generoso JS,Bellettini G,Vuolo F,Petronilho F,Feier G,Comim CM,Quevedo J,Dal-Pizzol F.Antibiotic therapy prevents, in part, the oxidative stress in the rat brain after meningitis induced by Streptococcus pneumoniae.Neurosci Lett. 2010;478:93-6.
31. Scheld WM,Koedel U,Nathan B,Pfister HW.Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury.J Infect Dis. 2002;186:S225-33.
32. Szabo C.Multiple pathways of peroxynitrite cytotoxicity.Toxicol Lett. 2003;140-141:105-12.
33. Mayhan WG.Nitric oxide donor-induced increase in permeability of the blood-brain barrier.Brain Res. 2000;866:101-8.
34. Lukes A,Mun-Bryce S,Lukes M,Rosenberg GA.Extracellular matrix degradation by metalloproteinases and central nervous system diseases.Mol Neurobiol. 1999;19:267-84.
35. Sellebjerg F,Sorensen TL.Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.Brain Res Bull. 2003;61:347-55.
36. Hsieh HL,Wang HH,Wu CY,Tung WH,Yang CM.Lipoteichoic acid induces matrix metalloproteinase-9 expression via transactivation of PDGF receptors and NF-kappaB activation in rat brain astrocytes.Neurotox Res. 2010;17:344-59.
37. Woessner JF.The family of matrix metalloproteinases.Ann N Y Acad Sci. 1994;732:11-21.
38. Rosenberg GA,Kornfeld M,Estrada E,Kelley RO,Liotta LA,Stetler-Stevenson WG.TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase.Brain Res. 1992;576:203-7.
39. Paul R,Koedel U,Winkler F,Kieseier BC,Fontana A,Kopf M,Hartung HP,Pfister HW.Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis.Brain. 2003;126:1873-82.
40. Paul R,Lorenzl S,Koedel U,Sporer B,Vogel U,Frosch M,Pfister HW.Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.Ann Neurol. 1998;44:592-600.
41. Leppert D,Leib SL,Grygar C,Miller KM,Schaad UB,Hollander GA.Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.Clin Infect Dis. 2000;31:80-4.
42. Barichello T,Silva GZ,Generoso JS,Savi GD,Michelon CM,Feier G,Comim CM,Quevedo J.Time-dependent behavioral recovery after pneumococcal meningitis in rats.J Neural Transm. 2010;117:819-26.
43. Barichello T,Milioli G,Generoso JS,Cipriano AL,Costa CS,Moreira AP,Vilela MC,Comim CM,Teixeira AL,Quevedo J.Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.J Neural Transm. 2012;119:653-60.
44. Leib SL,Leppert D,Clements J,Tauber MG.Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.Infect Immun. 2000;68:615-20.
45. Sellner J,Leib SL.In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation.Neurobiol Dis. 2006;21:647-56.